Search Results - "Fabbiani, M."

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients by CICCARELLI, N, FABBIANI, M, DI GIAMBENEDETTO, S, FANTI, I, BALDONERO, E, BRACCIALE, L, TAMBURRINI, E, CAUDA, R, DE LUCA, A, SILVERI, M. C

“…Despite the availability of potent antiretroviral regimens (combination antiretroviral therapy [cART]), HIV-associated neurocognitive disorders (HAND) are…”
Get full text

Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients by Paglicci, L., Borgo, V., Lanzarone, N., Fabbiani, M., Cassol, C., Cusi, MG, Valassina, M., Scolletta, S., Bargagli, E., Marchetti, L., Paladini, P., Luzzi, L., Fossi, A., Bennett, D., Montagnani, F.

“…To evaluate incidence of and risk factors for respiratory bacterial colonization and infections within 30 days from lung transplantation (LT). We…”
Get full text

Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe by Rossetti, Barbara, Fabbiani, Massimiliano, Di Carlo, Domenico, Incardona, Francesca, Abecasis, Ana, Gomes, Perpetua, Geretti, Anna Maria, Seguin‐Devaux, Carole, Garcia, Federico, Kaiser, Rolf, Modica, Sara, Shallvari, Adrian, Sönnerborg, Anders, Zazzi, Maurizio, Abecasis, A., Bobkova, M., Seguin‐Devaux, C., Fabbiani, M., Garcia, F., Geretti, A. M., Gomes, P., Incardona, F., Kaiser, R., Paredes, R., Rossetti, B., Sayan, M., Sönnerborg, A., Vandamme, A. M., Zazzi, M.

“…Objectives To explore the effectiveness and durability of integrase strand transfer inhibitor (INSTI)‐based regimens in pre‐treated subjects. Methods…”
Get full text

Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patients by Fabbiani, M, Ciccarelli, N, Tana, M, Farina, S, Baldonero, E, Di Cristo, V, Colafigli, M, Tamburrini, E, Cauda, R, Silveri, MC, Grima, P, Di Giambenedetto, S

“…Objectives The aim of the study was to investigate the relationship between metabolic comorbidities, cardiovascular risk factors or common carotid intima‐media…”
Get full text

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy by Borghetti, A, Baldin, G, Ciccullo, A, Gagliardini, R, D'Avino, A, Mondi, A, Ciccarelli, N, Lamonica, S, Fanti, I, Trecarichi, E, Fabbiani, M, Cauda, R, De Luca, A, Di Giambenedetto, S

Get full text

Effective SERS substrate obtained by Au deposition at silica surfaces through a top down method by A. Damin, P. Ivanchenko, M. Fabbiani, G. Martra

“…Background: In the last years some of us developed methods for preparing, through simple synthesis protocols, gold nanoparticles supported on silica surfaces:…”
Get full text

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy by Torti, C., Prosperi, M., Motta, D., Digiambenedetto, S., Maggiolo, F., Paraninfo, G., Ripamonti, D., Cologni, G., Fabbiani, M., Caputo, S.L., Sighinolfi, L., Ladisa, N., El-Hamad, I., Quiros-Roldan, E., Frank, I.

“…We evaluated factors associated with normalization of the absolute CD4+ T-cell counts, per cent CD4+ T cells and CD4+/CD8+ T-cell ratio. A multicentre…”
Get full text

Initial antifungal strategy does not correlate with mortality in patients with candidemia by Murri, R., Scoppettuolo, G., Ventura, G., Fabbiani, M., Giovannenze, F., Taccari, F., Milozzi, E., Posteraro, B., Sanguinetti, M., Cauda, R., Fantoni, M.

“…The incidence of Candida bloodstream infections (BSIs) has increased over time, especially in medical wards. The objective of this study was to evaluate the…”
Get full text

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort by Taramasso, L, Fabbiani, M, Nozza, S, De Benedetto, I, Bruzzesi, E, Mastrangelo, A, Pinnetti, C, Calcagno, A, Ferrara, M, Bozzi, G, Focà, E, Quiros‐Roldan, E, Ripamonti, D, Campus, M, Celesia, BM, Torti, C, Cosco, L, Di Biagio, A, Rusconi, S, Marchetti, G, Mussini, C, Gulminetti, R, Cingolani, A, d’Ettorre, G, Madeddu, G, Franco, A, Orofino, G, Squillace, N, Muscatello, A, Gori, A, Antinori, A, Tambussi, G, Bandera, A

“…Objectives The aim of this study was to evaluate the factors that can influence an incomplete viral response (IVR) after acute and early HIV infection (AEHI)…”
Get full text

Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients by Ciccarelli, N., Fabbiani, M., Grima, P., Falasca, K., Tana, M., Baldonero, E., Colafigli, M., Silveri, M. C., Vecchiet, J., Cauda, R., Di Giambenedetto, S.

“…Purpose Our aim was to explore the interplay between human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections in the expression of cognitive…”
Get full text

Lipid-lowering effect of tenofovir in HIV-infected patients by FABBIANI, Massimiliano, BRACCIALE, Laura, DOINO, Maria, SIDELLA, Letizia, FARINA, Salvatore, DI CRISTO, Valentina, CAUDA, Roberto, DE LUCA, Andrea, DI GIAMBENEDETTO, Simona

Get full text

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study by Mondi, A, Fabbiani, M, Ciccarelli, N, Colafigli, M, D'Avino, A, Borghetti, A, Gagliardini, R, Cauda, R, De Luca, A, Di Giambenedetto, S

“…AtLaS was a single-arm pilot study that demonstrated promising efficacy and safety of treatment simplification to a dual regimen with atazanavir/ritonavir +…”
Get full text

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First‐Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen by Fabbiani, M, Zaccarelli, M, Latini, A, Sterrantino, G, D'Ettorre, G, Grima, P, Mondi, A, Rossetti, B, Borchi, B, Giuliani, M, Antinori, A, De Luca, A, Di Giambenedetto, S

“…Objectives Despite not being approved in Europe as first‐line therapy, the efavirenz (EFV)‐containing single tablet regimen (STR) is frequently used in…”
Get full text

Mid‐dosing interval concentration of atazanavir and virological outcome in patients treated for HIV‐1 infection by Fabbiani, M, Di Giambenedetto, S, Ragazzoni, E, Colafigli, M, Prosperi, M, Cauda, R, Navarra, P, De Luca, A

“…Objectives We investigated the clinical significance of monitoring the mid‐dosing interval atazanavir (ATV) concentration (measured 12 ± 2 h after intake; C12…”
Get full text

Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure by Fabbiani, M., Bracciale, L., Ragazzoni, E., Santangelo, R., Cattani, P., Di Giambenedetto, S., Fadda, G., Navarra, P., Cauda, R., De Luca, A.

“…Purpose The relationship between antiretroviral pharmacokinetic exposure and acquisition of human immunodeficency virus-1 (HIV-1) drug resistance mutations…”
Get full text

Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis by Gagliardini, R., Fabbiani, M., Fortuna, S., Visconti, E., Navarra, P., Cauda, R., Colafigli, M., De Luca, A., Trecarichi, E. M., Di Giambenedetto, S.

“…Etravirine is metabolized by three cytochrome P450 enzymes that are in turn induced by rifampin. Consequently, co-administration of etravirine and rifampin is…”
Get full text

Impact of Hepatitis B Vaccination in Children Born to HBsAg-Positive Mothers: a 20-year Retrospective Study by Bracciale, L, Fabbiani, M, Sansoni, A, Luzzi, L, Bernini, L, Zanelli, G

“…Background: Preventive measures remain the best approach to control the spread of hepatitis B virus (HBV) infection. Patients and Methods: To evaluate the…”
Get full text

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007–2009 by Di Giambenedetto, S., Prosperi, M., Fanti, I., Bruzzone, B., Paolucci, S., Penco, G., Meini, G., Di Biagio, A., Paolini, E., Micheli, V., Meraviglia, P., Castelli, P., Corsi, P., Gonnelli, A., Fabbiani, M., Zazzi, M., De Luca, A.

“…We analysed trends of human immunodeficiency virus type 1 (HIV-1) drug resistance during 2007–2009 in the Italian national HIV drug resistance database ‘ARCA’…”
Get full text

Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection by Di Giambenedetto, S, Zileri Dal Verme, L, Sali, M, Farina, S, Di Cristo, V, Manzara, S, De Luca, A, Pignataro, G, Prosperi, M, Di Franco, A, Gentiloni Silveri, N, Delogu, G, Cauda, R, Fabbiani, M, Fadda, G

“…The purpose of this study was to describe epidemiological, clinical and microbiological characteristics of confirmed novel influenza A (H1N1) infection,…”
Get full text

O4 Early start of antiretroviral therapy (ART) during primary HIV infection (PHI) is associated with faster optimal immunological recovery: results of Italian Network of ACuTe HIV InfectiON (INACTION) retrospective study by A. Muscatello, A. Bandera, M. Fabbiani, I. De Benedetto, A. Ammassari, A. Antinori, A. Calcagno, B.M. Celesia, A. Cingolani, G. d'Ettorre, A. Di Biagio, E. Focà, E. Girardi, R. Gulminetti, G. Madeddu, G. Marchetti, C. Mussini, S. Nozza, G. Orofino, D. Ripamonti, S. Rusconi, G. Tambussi, A. Gori

Get full text